Viewing StudyNCT04439110



Ignite Creation Date: 2024-05-06 @ 2:49 PM
Last Modification Date: 2024-10-26 @ 1:38 PM
Study NCT ID: NCT04439110
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-08
First Post: 2020-06-18

Brief Title: Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes MATCH-Subprotocol Q
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Refractory Multiple Myeloma
Advanced Lymphoma
Advanced Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm
Refractory Lymphoma
Refractory Malignant Solid Neoplasm
Keywords: